The voucher allows for an expedited 6-month review of the drug’s pending New Drug Application with the FDA.
Alicia Bigica
Advertisement
Alicia Bigica is the Associate Editorial Director for NeurologyLive. Prior to joining MJH Life Sciences in 2019, she helped launch leading resources for medical news in the neurology and dermatology specialties. Follow her on Twitter @aliciabigica or email her at [email protected].
Articles by Alicia Bigica
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Parkinson Agent Tavapadon Shows Continued Efficacy, Safety in Phase 3 TEMPO-4 Trial
2
NeurologyLive® Brain Games: October 19, 2025
3
RWJBarnabas and Rutgers Health Researchers Pursue Advanced Neurostimulation Technology to Treat Epileptic Seizures
4
Refining Neonatal Continuous EEG Guidelines Through Evidence and Family Collaboration: Adam Numis, MD
5
